7 doctors get probation, must pay $2.6 million for importing illegal cancer drugs
Five months after they were first charged in federal court with the crime, seven Ohio oncologists have been ordered to collectively pay nearly $2.6 million in fines and restitution for importing cancer drugs not approved for use in the United States by the Food and Drug Administration. The doctors, who also were sentenced to probation, admitted to causing the shipment of misbranded drugs, a misdemeanor violation of the Food, Drug and Cosmetic Act. The men, initially charged in criminal informations rather than grand jury indictments - which usually indicates the defendants are cooperating with federal prosecutors - were accused of obtaining drugs from outside the U.S. The drugs named included Zometa, Kytril, Taxotere, Gemzar, Eloxatin and others.
- Interventional Radiology No Longer a Sub-Specialty
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Acute Kidney Injury Gets New Focus
- Transforming Cancer Care
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- mHealth Tackles Readmissions
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Sharp HealthCare Leaves Pioneer ACO Program
- MA an Insurance Proving Ground for Providers